Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-14

FDA Approved: ALLERGY RELIEF-D — Original Application (HEB)

View source ↗

Summary

FDA approves ALLERGY RELIEF-D, a combination product of loratadine and pseudoephedrine sulfate, under an original application by HEB, for relief of symptoms of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF-D (Loratadine and pseudoephedrine sulfate)

Snippet

ORIG AP for ALLERGY RELIEF-D (LORATADINE AND PSEUDOEPHEDRINE SULFATE)